Publication | Closed Access

EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer

Surgical OncologyWeek Oral RegimenRadiation TherapyGastrointestinal OncologyMedicineMetronomic TherapyIntravenous Mitomycin CSurgeryAnal CancerOncologyRadiation OncologyCancer Research